MUMBAI: In a veritable setback to the Indian pharmaceutical industry, the Supreme Court has dismissed a special leave petition filed by the Indian Pharmaceutical Alliance to block a government order notified two years ago to control prices of over a hundred drugs that were not part of the National List of Essential Medicines (NLEM).

The Indian Pharmaceutical Alliance is a grouping of top Indian drug makers. A July 2014 notification by the National Pharmaceutical Pricing Authority (NPPA) had invoked Paragraph 19 of the Drug Price Control Order, citing extraordinary circumstances for a band of anti-diabetes and heart disease drugs and fixed their price caps in the ‘public interest’.


For more details click here